-+ 0.00%
-+ 0.00%
-+ 0.00%
Mentari Therapeutics Appoints Deloitte as Auditor
Share
Listen to the news
Mentari Therapeutics Appoints Deloitte as Auditor
  • Mentari Therapeutics engaged Deloitte & Touche on November 19, 2026, as auditor for the fiscal year ending December 31, 2026.
  • The appointment follows the November 17, 2026, dismissals of CBIZ, InMed's pre-merger auditor, and Ernst & Young, Mentari's pre-merger auditor.
  • Neither outgoing auditor had accounting disagreements or reportable events during the periods reviewed through November 17, 2026.
  • Both auditors' reports included explanatory paragraphs citing substantial doubt about their respective clients' ability to continue as going concerns.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mentari Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-468852), on November 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending